hVIVO

Acquisition of CRS Berlin

  • Aug 27 2026, 07:57 IST/BST
  • Colin Grant
  • Company Report
  • 6 page(s)
  • Sectors : Pharma and healthcare
  • Companies : hVIVO

Ratings and price correct at time of issue.

  • hVIVO

    Closing Price: 6.4p

  • RATING 11/10/23

  • PREVIOUS RATING 17/02/20

    UNDER REVIEW

Person's Name

Colin Grant

Analyst

DAVY VIEW

hVIVO has announced the acquisition of CRS (Clinical Research Services) Berlin for a nominal upfront consideration and potential earn-out. It is a strategic bolt-on acquisition that has operated in close partnership with hVIVO following its previous acquisitions of CRS Mannheim and CRS Kiel in January 2025.

View full article

Download full report with analyst certification and important disclosures

Aug 27 2026, 07:57 IST/BST

Download